Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics

Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program

Hemispherian raises seed funding for novel cancer therapeutics

World Leaders in Brain Cancer Join Hemispherian’s Clinical Advisory Board, Chaired by Dr. Roger Stupp

Hemispherian is delighted to announce its first granted patent

Hemispherian completes its seed financing and appoints Masha Strømme as Chair of the Board

Josipa Matic joins Hemispherian as Medicinal chemist. Welcome!